Hester Biosciences Ltd Financials
Company Logo

Hester Biosciences Ltd Financial Statement

Hester Biosciences Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Jun 2025
Revenue64.44
Operating Expense51.08
Net Profit7.84
Net Profit Margin12.17
Earning Per Share9.21
EBIDTA12.75
Effective Tax Rate13.77

Hester Biosciences Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Total Revenue Annual286.47
Operating Expenses Annual235.52
Operating Profit Annual55.71
Interest Annual5.37
Depreciation8.58
Net Profit Annual31.84
Tax Annual9.92

Hester Biosciences Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Cash Flow at the Beginning1.97
Cash Flow from Operations63.97
Cash Flow from Investing-19.04
Cash Flow from Financing-46.35
Cash Flow at the End0.55

Hester Biosciences Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
PBDIT Margin (%)19.45
PBIT Margin (%)16.45
PBT Margin (%)13.39
Net PROFIT Margin (%)11.11
Return On Networth / Equity (%)9.77
Return On Networth /Employed (%)9.47
Return On Assets (%)6.45
Total Debt / Equity (X)0.36
Asset Turnover Ratio (%)0.58

Hester Biosciences Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Fixed Assets Annual111.49
Total Current Assets Annual185.24
Non Current Assets Annual360.76
Total Shareholders Funds Annual339.09
Total Assets Annual546.00

Hester Biosciences Ltd Earning Calls

EPS (INR)

Expected

19.32

Reported

20.33

Surprise

5.23%

Mar 2025

EPS beaten by 5.23%

Dec 2024

EPS beaten by 19.74%

Sep 2024

EPS beaten by -2.12%

FAQS on Hester Biosciences Ltd Financials

As of Aug 2, 2025, Hester Biosciences Ltd has a market capitalization of 1,066.68 Cr. Value Research classifies it as a Small-Cap company.

Yes, Hester Biosciences Ltd is with a debt-to-equity ratio of 0.31.

In FY 2024 , Hester Biosciences Ltd recorded a total revenue of approximately 286.47 Cr marking a significant milestone in the company's financial performance.

Hester Biosciences Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately -0.1% and 0.1% annually, respectively..

Hester Biosciences Ltd's current PE ratio is 33.50.

Hester Biosciences Ltd's ROCE averaged 9.5% from the FY ending March 2023 to 2025, with a median of 9.5%. It peaked at 10.5% in March 2023, reflecting strong capital efficiency over the period..

Hester Biosciences Ltd's latest EBIT is Rs. 47.13 Cr, surpassing the average EBIT of Rs. 46.46 Cr over the 5 years..

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions